Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 13, 2020

SELL
$34.44 - $43.75 $172,200 - $218,750
-5,000 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$27.12 - $45.97 $135,600 - $229,850
5,000 New
5,000 $305,000
Q1 2020

May 15, 2020

SELL
$26.16 - $63.5 $567,802 - $1.38 Million
-21,705 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$46.96 - $61.67 $1.02 Million - $1.34 Million
21,705 New
21,705 $1.91 Million
Q3 2019

Nov 14, 2019

SELL
$59.47 - $93.1 $1.64 Million - $2.56 Million
-27,510 Closed
0 $0
Q2 2019

Aug 14, 2019

SELL
$75.84 - $105.21 $1.58 Million - $2.2 Million
-20,892 Reduced 43.16%
27,510 $3.5 Million
Q1 2019

May 14, 2019

BUY
$64.44 - $104.11 $1.06 Million - $1.71 Million
16,391 Added 51.2%
48,402 $7.62 Million
Q4 2018

Feb 14, 2019

SELL
$59.1 - $93.26 $1.25 Million - $1.97 Million
-21,074 Reduced 39.7%
32,011 $3.18 Million
Q3 2018

Nov 14, 2018

SELL
$88.86 - $117.49 $287,817 - $380,550
-3,239 Reduced 5.75%
53,085 $7.75 Million
Q2 2018

Jul 19, 2018

SELL
$99.64 - $127.59 $1.29 Million - $1.66 Million
-12,991 Reduced 18.74%
56,324 $8.84 Million
Q1 2018

May 10, 2018

BUY
$105.8 - $150.94 $839,840 - $1.2 Million
7,938 Added 12.93%
69,315 $11.8 Million
Q4 2017

Feb 14, 2018

SELL
$81.25 - $130.7 $595,725 - $958,292
-7,332 Reduced 10.67%
61,377 $10.9 Million
Q3 2017

Nov 14, 2017

BUY
$57.74 - $91.42 $3.97 Million - $6.28 Million
68,709
68,709 $9.44 Million

Others Institutions Holding BLUE

About bluebird bio, Inc.


  • Ticker BLUE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 77,121,800
  • Market Cap $27M
  • Description
  • bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...
More about BLUE
Track This Portfolio

Track Fred Alger Management, LLC Portfolio

Follow Fred Alger Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fred Alger Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fred Alger Management, LLC with notifications on news.